id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-03-20 20:52:47
expired found date
-
created at
2024-06-09 06:57:51
updated at
2026-01-02 05:00:48
length
16
crc
49133
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
78394
mp size raw text
2389
mp inner links count
0
mp inner links status
20 (imported)
title
Boundless Bio
description
We at Boundless Bio are pioneers in understanding and treating the most intractable cancers. We have charted a new spatial map of the cancer genome within cancer cells and are harnessing our scientifi
site name
Boundless Bio
author
updated
2025-12-21 10:14:16
raw text
Boundless Bio Why We’re Here Who We Are What We Do What’s New Work With Us Boundless Bio Boundless Bio Who We Are We are a team of bold innovators dedicated to delivering novel therapies for patients with intractable oncogene amplified cancers. Boundless Bio Boundless Bio Why We're Here Our groundbreaking science turns one of cancer’s key enabling mechanisms, extrachromosomal DNA (ecDNA), a root cause of oncogene amplifications found in over 14% of cancer patients, into one of its critical vulnerabilities. Boundless Bio Boundless Bio What We Do Boundless Bio is a clinical stage, next-generation precision oncology company advancing a robust pipeline of the next wave of cancer medicines, ecDNA-directed therapies (ecDTx). prev next 1 | 3 Greater than 25% of all cancers have oncogene amplifications More than 5 million newly diagnosed cancers each year around the world harbor oncogene amplifications. Unfortunately, there are no effective tre...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1912
text words
351
text unique words
169
text lines
42
text sentences
12
text paragraphs
7
text words per sentence
29
text matched phrases
20
text matched dictionaries
4
links self subdomains
0
links other subdomains
0
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
2 - linkedin.com, twitter.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-21 10:14:16
rss path
rss status
32 (unknown)
rss found date
2024-03-30 03:25:05
rss size orig
601
rss items
0
rss spam phrases
0
rss detected language
126 (language undetectable (empty document, too short, or engines disagree))
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
34
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-03-29 04:50:27
sitemap process date
2025-03-01 22:21:16
sitemap first import date
-
sitemap last import date
2025-03-21 00:08:36